Search Weight Loss Topics:

Page 45«..1020..44454647..5060..»

Home » Testosterone » Page 45

LAUSANNE, Switzerland (Reuters) - Double Olympic 800 metres champion Caster Semenya has lost her appeal to the Swiss Federal Tribunal (SFT) to set aside a 2019 Court of Arbitration (CAS) ruling that female athletes with high natural testosterone levels must take medication to reduce it.

But the South African has indicated that she may continue her battle in the European and domestic courts ahead of the Olympics in Tokyo next year, vowing to "fight for human rights".

Semenya approached the tribunal in May last year after CAS, sport's highest court, ruled that the regulations of the sport's governing body World Athletics were necessary for athletes with differences in sexual development (DSDs) in races ranging from 400 metres to a mile to ensure fair competition.

The tribunal found that subjecting female athletes to drug or surgical interventions as a precondition to compete does not amount to a violation of Swiss public policy.

Testosterone increases muscle mass, strength and haemoglobin, which affects endurance.

Some competitors have said women with higher levels of the hormone have an unfair advantage.

"I am very disappointed by this ruling, but refuse to let World Athletics drug me or stop me from being who I am," Semenya said in the statement on Tuesday.

"Excluding female athletes or endangering our health solely because of our natural abilities puts World Athletics on the wrong side of history.

"I will continue to fight for the human rights of female athletes, both on the track and off the track, until we can all run free the way we were born."

World Athletics welcomed the ruling, which they said vindicates their stance in creating a level playing field for all athletes.

"Throughout this long battle, World Athletics has always maintained that its regulations are lawful and legitimate, and that they represent a fair, necessary and proportionate means of ensuring the rights of all female athletes to participate on fair and equal terms," the governing body said in a statement.

"We are very pleased that the highest court in Switzerland has now joined with the highest court in sport in endorsing World Athletics' arguments."

But Semenya's lawyer, Greg Nott, suggested this was far from the end of the road for his client.

"This setback will not be the end of Casters story," he said. "The international team (of lawyers) is considering the judgment and the options to challenge the findings in European and domestic courts."

(Reporting by Nick Said in Cape Town; Editing by Ken Ferris)

Read more:
Athletics: Semenya loses appeal against CAS ruling over testosterone regulations - Yahoo Sports

Data Bridge Market Research has recently published the Global research Report TitledTestosterone Replacement Therapy Market. The study provides an overview of current statistics and future predictions of the Global Testosterone Replacement Therapy Market.The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data.

Get a Free Sample Copy Of This Research Report + All Related Graphs & Charts:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-testosterone-replacement-therapy-market&utm_source=&kA

The report gives explanations about market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the key market players. With this large scale Testosterone Replacement Therapy Marketreport, it can also be estimated how the actions of key players are affecting the sales, import, export, revenue and CAGR values. The report also helps analyze the most appropriate method for the distribution of certain products. This market study also estimates the market status, market share, growth rate, sales volume, future trends, market drivers, market restraints, revenue generation, opportunities and challenges, risks and entry barriers, sales channels, and distributors

Top Key Vendors Covered in the report:

AbbVie Inc., Bausch Health Companies Inc., Allergan, Amneal Pharmaceuticals LLC, Pfizer Inc., Endo International plc, Teva Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Inc., Lupin, Novartis AG, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC, among others.

Regions included:

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

How Does This Market Insights Help?

Key Pointers Covered in the Testosterone Replacement Therapy Market Industry Trends and Forecast to 2026

Why choose us:

1. We share precise and exact information about the market forecast;2. Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment;3. The analysis acknowledges that the sector players key drivers of both conflicts and Testosterone Replacement Therapy growth assess the impact of limitations as well as the opportunities on the sector;4. Data regarding Testosterone Replacement Therapy industry share by every item fragment, alongside their reasonable worth, have been served in the report;5. We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players. This will help the company to increase its efficiency;6. Our report helps readers decipher the current and future constraints of the Testosterone Replacement Therapy market and optimal business strategies to enhance market development;

A complete value chain of the global Testosterone Replacement Therapy market is presented in the research report. It is associated with the review of the downstream and upstream components of the Testosterone Replacement Therapy Market. The market is bifurcated on the basis of the categories of products and customer application segments. The market analysis demonstrates the expansion of each segment of the global Testosterone Replacement Therapy market. The research report assists the user in taking a decisive step that will be a milestone in developing and expanding their businesses in the global Testosterone Replacement Therapy market.

Get Table Of Contents of This Premium Research For Free: https://www.databridgemarketresearch.com/toc/?dbmr=global-testosterone-replacement-therapy-market&utm_source=&KA

Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Chapter 2: Executive Summary

Chapter 3: Testosterone Replacement Therapy Industry Insights

Chapter 4: Testosterone Replacement Therapy Market, By Region

Chapter 5: Company Profile

And More..

For More Information or Query or Customization before Buying, Visit at: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-testosterone-replacement-therapy-market&utm_source=&KA

Customization of the Report

Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thanks for reading this article you can also get individual chapter wise section or region wise report versions like North America, Europe, MEA or Asia Pacific.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rates

Contact:

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

[emailprotected]

Follow this link:
Testosterone Replacement Therapy Market Increasing Demand and Generate Huge Profits by 2020 2027 - The Market Correspondent

The latest release from SMI with title Testosterone Replacement Therapy Market Research Report 2020-2027 (by Product Type, End-User/Application, and Regions/Countries) evaluates each segment of the Testosterone Replacement Therapy market in detail so that readers can be guided about future opportunities and high-profit areas of the industry. In inclusion, it presents an encyclopedic study of important market dynamics, including Market Size, Share, Growth Initiators, Trends, Obstacles, Challenges, and opportunities.

In addition, the statistical investigation of the report focuses on product specifications, costs, capacity, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and end-user industry listings have been systematically studied with vendors in this market. Product flows and distribution channels were also presented in this research report.

Download FREE Sample Copy of This Report: https://www.stratagemmarketinsights.com/sample/14818

The scope of the report extends from market scenarios to price comparisons between key players, costs, and benefits in specific market regions. Numerical data is backed up with statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, and PESTLE analysis. Statistics are presented in graphical format for a clear understanding of facts and figures.

The major manufacturers covered in this report:

AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

Global Testosterone Replacement Therapy Market Segmentations

The segmentation chapter allows the reader to understand aspects of the global Testosterone Replacement Therapy market such as products/services, available technologies, and applications. This chapter is written in a way that describes the years of development and the process that will take place in the years to come. Research reports also provide insightful information on emerging trends that can define the progress of these segments over the next few years.

Regional Insights of Testosterone Replacement Therapy Market

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa, and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come. While Testosterone Replacement Therapy Market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and thats the reason most of the time the US dominates the global markets. Testosterone Replacement Therapy Market in the South, America region is also expected to grow in the near future.

Report Covers Impacts of COVID-19 to the market

The on-going pandemic has overhauled various facets of the market. This research report provides financial impacts and market disturbancein the Testosterone Replacement Therapy market. It also includes analysis of the potentially lucrative opportunities and challenges in the foreseeable future. DataIntelo has interviewed various delegates of the industry and got involved in the primary and secondary research to confer the clients with information and strategies to fight against the market challenges amidst and after the COVID-19 pandemic.

Get Exclusive Discount Up to 50%: https://www.stratagemmarketinsights.com/discount/14818

Key Questions Answered in Report:

Global Testosterone Replacement Therapy Market Industry Analysis assists clients with customized and syndicated reports of significant importance to the experts involved in data and market analysis. The report also calls for market-driven results that drive a feasibility study for customer needs. SMI guarantees validated and verifiable aspects of market data operating in real-time scenarios. Analytical studies are conducted to confirm customer needs with a thorough understanding of market capabilities in real-time scenarios.

In conclusion, the Testosterone Replacement Therapy Market report is your trusted source for accessing research data that is expected to exponentially accelerate your business. This report provides information such as economic scenarios, benefits, limitations, trends, market growth rates, and figures. The SWOT analysis is also incorporated into the report along with the guess attainability survey and venture revenue survey.

Furthermore, the years considered for the study are as follows:

Historical year 2014-2018Base year 2019Forecast period 2020 to 2027

If you have any special requirements please let us know we will offer you a report as you want.

Talk to Our Analyst for any Special Requirement/Customization of the report: https://www.stratagemmarketinsights.com/speakanalyst/14818

Explore By SJ

Follow this link:
Testosterone Replacement Therapy Market 2020 Movements by Trend Analysis, Market Size, Growth Status, Revenue Expectation to 2027 - Scientect

If you are trying to take your health to new levels, start with the health of your gut. Several experts have written about the gut-brain connection, but its important to recognize that it also affects your hormones.

When your bodys hormone levels are diminished youll have problems that can get you down. So what issues come into play?

Heres how gut health has an effect on your hormone levels and other issues of wellness.

How Gut Health Affects Your Hormones

Gut health and hormone levels are directly linked. This is why its so important to eat the right foods and to take herbs and other products that will keep your hormones in check.

Consider these ways that gut health and hormones go hand in hand:

1. It Affects Your Mood and Stress Levels

Its not uncommon to have gut issues whenever youre stressed out. Cortisol is a hormone linked to stress levels that your body produces when youre in a constant fight or flight state.

When this happens, you might experience stomach pains and leaky acid in your gut. Indigestion is a symptom that many people deal with when theyre chronically stressed.

Many people drink coffee every day to get energy, not recognizing that it can actually throw their hormones out of whack. It taps out your adrenaline glands, which creates imbalances that deplete your other hormones.

2. Poor Gut Health Can Throw Your Estrogen Out of Whack

People that have poor gut health also experience imbalances in their estrogen levels. This happens when your gut becomes inflamed.

As a result, you might start to experience mood swings and weight gain. Getting your gut health under control keeps your estrogen levels healthy so that you can bypass these sorts of issues.

3. People Deal With Gut Issues When They Have an Infection

Gut health issues also serve as warning signs. For instance, people often experience problems with gut health whenever they have an infection.

If you are experiencing gut issues out of nowhere when you have otherwise had a healthy gut, take the time to visit a physician so that you can get a clean bill of health or find out what is going on.

4. When You Eat Unhealthily it Lowers Your Testosterone

Eating junk food will cause you to gain an inordinate amount of weight, but will also damage your hormone levels. When youre dealing with obesity or just carrying around some extra weight, it causes your testosterone levels to go down.

Keeping some muscle mass on your body helps with your testosterone levels while carrying high body fat causes a dip.

Its always important to listen to your bodys warning signs and consider your overall health.

Sites likehttps://microbeformulas.com/can sell you all sorts of herbs and other products that can help you balance your gut health.

Take Care of Your Gut Health and Overall Health

Consider these tips to learn more about how gut health can affect you. These issues are linked, so study up on gut health and all of its implications.

Let these tips help you and check backto learn more about health and fitness.

Read the original post:
Gut Health and Hormones: How the Two Are Intrinsically Linked - Liist Studio

Testosterone Replacement Therapy Market 2018: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2024

The report provides both quantitative and qualitative information of global Testosterone Replacement Therapy market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Testosterone Replacement Therapy is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Testosterone Replacement Therapy market was valued at USD _ million/billion.

This research report based on Testosterone Replacement Therapy market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Testosterone Replacement Therapy market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Testosterone Replacement Therapy industry.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2643091&source=atm

Testosterone Replacement Therapy Market Overview:

The Research projects that the Testosterone Replacement Therapy market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

Leading manufacturers of Testosterone Replacement Therapy Market:

Competition AnalysisIn the competitive analysis section of the report, leading as well as prominent players of the global Testosterone Replacement Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Replacement Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Replacement Therapy market.The following manufacturers are covered in this report:AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus PharmaceuticalsTestosterone Replacement Therapy Breakdown Data by TypeGelsInjectionsPatchesOtherTestosterone Replacement Therapy Breakdown Data by ApplicationHospitalsClinicsOthers

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2643091&source=atm

Some important highlights from the report include:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2643091&licType=S&source=atm

The Questions Answered by Testosterone Replacement Therapy Market Report:

And Many More.

Read the original here:
Testosterone Replacement Therapy Projected to Witness Vigorous Expansion by 2019-2026 - The Daily Chronicle

Lifting weights does a lot of things for women, but not among them is "bulk up."

Let's clear up one myth that runs rampant in the fitness industry: Women will not "bulk up" if they lift weights -- even heavy ones! People often use the term "bulky" in a negative way to describe others, typically women, who have large muscles or well-defined physiques.

As weightlifting gained popularity and edged its way into mainstream culture, many women developed a fear of turning into Arnold Schwarzenegger if they so much as touched a 10-pound dumbbell.

Marketing masterminds caught on and someone, somewhere invented the terms "lean muscle" and "tone up" to target women who wanted to exercise but not get "buff."

Our Health & Wellness newsletter puts the best products, updates and advice in your inbox.

We need to nix all of these terms from the fitness vernacular because first, women won't bulk up if they start lifting weights; second, lifting weights produces so many health benefits; and third, it's blatantly sexist to think women shouldn't look muscular anyway.

Here are four reasons to stop believing that strength training makes women bulky, plus several reasons to add weightlifting to your workout routine stat.

Now playing: Watch this: Amazon's Halo takes fitness tracking to new and uncomfortable...

7:07

This is good news for some, bad news for others -- it's great news for women who are afraid of packing on too much muscle. Building muscle is a long, slow process that requires years of consistency, dedication and effort.

Most people don't put in enough time or effort to create the kinds of physiques they're scared of. It takes several years to put on the kind of mass that bodybuilders have, and there's a reason professional bodybuilders are an elite few: They put in work that most people won't.

Real-life case in point: I've been lifting weights for more than seven years and I wouldn't call myself "bulky."

In general, womendon't produce as much testosterone as men. Testosterone production is a huge factor in your capacity for muscle growth, so this should automatically tell you that you won't turn into Wolverine overnight.

Of course, there are always exceptions: Some women have higher testosterone levels than other women, but even those with higher-than-average testosterone likely don't have enough to produce bulky muscles.

To build muscle, you must eat more calories than you burn. You can't grow new tissue out of nothing, so don't expect muscle growth if you're eating in a calorie deficit or even at maintenance. Many women don't eat enough calories or enough protein to support significant muscle growth.

For reference, the recommended calorie intake for a healthy woman is between 1,800 and 2,400 calories. If you exercise, you probably need to meet the higher end of that range, and potentially more if you're tall or very active. Unless you're eating more than your maintenance intake each day, don't worry about getting bulky.

Packing on a lot of muscle takes more calories, more protein and more testosterone than you might think.

Muscles don't grow in response to tasks they're used to. Your muscles need a challenge: If you're not progressively overloading your lifts on a regular basis, you're not encouraging your muscles to grow. They have no reason to get bigger if there is no demand.

To add more muscle mass, you need follow two primary rules with your workouts:

What's more is that those two techniques only work for so long -- eventually, as you get stronger, you'll also need to add in techniques like drop sets, super sets, pyramid sets and repping to failure to send stronger muscle-building signals to your brain.

Frequency is another key factor in building muscle. Studies show that when you train a muscle more often, it grows more in a shorter period of time. As with volume, however, there are caps on this concept. The stronger and fitter you get, the less of an impact frequency has on muscle growth.

Women who lift weights won't get bulky. They'll get strong, healthy, and probably more confident.

Women won't bulk up when they start lifting weights. What they will do, though, is lose body fat and earn the "toned" appearance so many people are after. Beyond aesthetics, women who lift weights will experience the numerous health benefits of resistance training.

Lifting weights can:

If those reasons aren't enough to pick up a pair of dumbbells, I don't know what is.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Read the original:
Does lifting weights make women bulky? The myth that won't die - CNET

SARASOTA, Fla., Sept. 1, 2020 /PRNewswire/ --Transcendent Publishing today announced the release of Male 2.0: Cracking the Code to Limitless Health and Vitality by author Tracy Gapin, MD, FACS. Since its August release, the book has already reached Amazon bestseller status. Dr. Gapin, a men's health and performance expert and member of the American Urological Association, provides a meaningful impact for men's health with this leading-edge approach.

Over the past thirty years, there has been a relentless population-based decline in mens' testosterone levels by over thirty percent. We've also seen a dramatic increase in the incidence of obesity. Over seventy percent of men are either overweight or obese, which is directly tied to energy, productivity, and overall health and performance. This has led to a men's health epidemic for the 159 million men in the United States.

The Male Method described throughout Male 2.0 was developed to help men lose weight, regain energy, optimize their hormones, and regain peak performance. "We need to go beyond testosterone. We need to take an individualized, systems-based approach to optimize men's health, performance and longevity," says Tracy Gapin, MD, FACS. "Driven by the power of epigenetics, genetics, peptides, and wearable technologies, we have gained incredible insight into some of the most misunderstood aspects of men's health and longevity."

JJ Virgin, New York Times Bestselling author of The Virgin Diet & Sugar Impact Diet said, "As a thought leader in men's health, Dr. Gapin has provided the modern-day blueprint to help men optimize their health and regain their vitality. Every man should read this book."

Clete Walker, CEO of Vituro Health, a prostate health company, said, "Male 2.0 is a revolution for men's health. After my father was diagnosed with prostate cancer, I made it my mission to seek out potential new modalities, and this data-driven approach is the future."

Male 2.0: Cracking the Code to Limitless Health and Vitalityis available on Amazon and during the month of September the print version is available for free at The Gapin Institute. http://www.GapinInstitute.com

About Tracy Gapin, MD FACS:Dr. Gapin is board-certified Urologist, world renowned Men's Health & Performance Expert, Author, and Professional Speaker. Using state-of-the-art biometric monitoring, nutrition and lifestyle intervention, Dr. Gapin coaches Fortune 500 executives and evolutionary leaders of business, sports medicine, and high performance. He specializes in cutting-edge precision medicine with an emphasis on epigenetics, providing men with a personalized path to optimizing health & performance. http://www.GapinInstitute.comEmail: [emailprotected]

About Transcendent Publishing:Since 2012, Transcendent Publishing has specialized in offering a variety of publishing and design services for today's indie author. http://www.transcendentpublishing.com

CONTACT:Leann Spofford[emailprotected]Tel: (941) 524-4592

SOURCE Gapin Institute

Home – MMG

Link:
Men's Health Expert Tracy Gapin, MD Unveils Male 2.0 with a Revolutionary Protocol to Conquer the Men's Health Epidemic - PRNewswire

Advances in imaging have made assessment of atherosclerosis non-invasive, while the EVAPORATE trial demonstrates how cardiac CT can assist in looking at a host of different therapies, said Matthew Budoff, MD, professor of medicine at the David Geffen School of Medicine at UCLA and investigator at The Lundquist Institute.

Transcript:

The American Journal of Managed Care (AJMC):In EVAPORATE the only secondary endpoint which did not achieve a significant difference between control and intervention groups was dense calcium. What might account for this?

Dr. Budoff: Calcification is probably the last of the stages of atherosclerosis, so it's the least modifiable. So we saw low attenuation plaque, the vulnerable, or necrotic, core changed a lot, fibrofatty plaque, the softer plaque, changed moderately and fibrous plaque change less and then calcified plaque change the least. So I think that actually makes sense from a biological mechanism, that the most earliest plaques and the most vulnerable plaques changed the most, and the more stable plaques, like those with a lot of fibrous tissue or those with dense calcium, changed less. The P-value for calcification in multivariate analysis was .0531. So, you know, from a purist standpoint, it didn't change significantly. But some people would say .053 is pretty close to .05 and is close to statistical significance. But either way, I think it makes sense biologically that the more stable plaque changes less than the earlier softer plaques.

AJMC: As reduction of triglycerides on its own is not producing the dramatic drop in CV events, what are your thoughts on expanding the scope of patients receiving icosapent ethyl (Vascepa)?

Dr. Budoff: While I agree that triglyceride lowering isn't the primary benefit, I think those with high triglycerides are still a potential target. We have a number of populations where the target population is based on an abnormality of something, but we don't always treat that specific thing. For many years, diabetes, for example, the presence of diabetes meant your high cardiovascular risk and the treatment wasn't control the Hemoglobin A1c, the treatment was add other therapies. I think we still should be using icosapent ethyl largely in patients who have elevated triglycerides because that's where the benefit was shown to be the greatest. We have data now from triglycerides of 135 and up, and this group is still high risk. I want to emphasize that patients with elevated triglycerides, maybe because of metabolic syndrome and diabetes, and other factors, patients with elevated triglycerides are high risk, and they appear to benefit from icosapent ethyl. Whether it works in patients with normal triglycerides, I think that does deserve further study. We could not address that in EVAPORATE, because we did the EVAPORATE trial the same as the REDUCE IT study, and both of them used entry criteria for triglycerides of 135 and up.

AJMC: Do you have any final thoughts you would like to share?

Dr. Budoff: Well, I just wanted to point out that the use of cardiac CT now has become highly reproducible. The reduction in radiation dose does allow us to do these type of trials, where we can do serial studies and assess does drug A do better than drug B, or does drug A do better than placebo over time .We've had some early studies looking at statins with this serial CT angiography and we've published on the testosterone, that testosterone increases atherosclerosis plaque in our placebo controlled randomized trial. Now we've been able to show that icosapent ethyl reduces plaque. So I do think that it's a nice model. It's not invasive, it's easy, but I do think it's an important way to assess some of the benefits without having to do intravascular ultrasound, and take patients to the catheterization lab twice, with all of the associated risks.

I think the advances in imaging have made our assessment of atherosclerosis now non-invasive. And I think that's an important part of the message of EVAPORATE, that this is a potential tool to look at a host of different therapies that we now have. We're now doing a trial with GLP-1 receptor agonists with semaglutide to see if that slows plaque progression, because that's also shown outcome benefit without a clear mechanism of action.

See more here:
Dr Matthew Budoff on the Benefits of Cardiac CT Use - AJMC.com Managed Markets Network

World Rugbys proposals to ban trans women from playing womens rugby have been criticised by dozens of academics, who have written to the sports governing body to insist there is no evidence that trans women pose a safety risk to others playing the sport.

The letter, which has been co-signed by 84 leading academics from a range of fields including sport, public health and sociology, also questions the science behind the proposed ban and warns it will discriminate against vulnerable people.

We are opposed to World Rugbys proposed ban of an entire population group from playing womens rugby: non-binary people assumed male at birth and transgender women, it says. There is no peer-reviewed, scientific evidence to justify a ban which would only be harmful to trans and gender diverse people.

The letter, which has been seen by the Guardian newspaper, also reminds World Rugby that this is not a fringe population affected and that recent research by the American centers for disease control and prevention found 3.4 per cent of American school students (year 9-12) identify as trans or gender diverse, or they were not sure about their gender identity.

The letter adds: to develop appropriate guidelines requires ongoing work with transgender athletes and community representatives, and engagement with rigorous, peer-reviewed evidence. These guidelines fail on both accounts.

However, World Rugby has issued a robust defence of the research on which its recommendations are based, as well as its application of that research, which has concluded there is a minimum of 20 per cent to 30 per cent increase in injury risk factors when typical male-bodied and female-bodied players are involved in tackles even when trans women suppress their testosterone in line with International Olympic Committee rules.

From the outset, we have sought to balance inclusion, safety and fairness within the context of a physical sport based on strength, power, speed and contact, World Rugby said in a statement. However, the scientific medical evidence position regarding the impact of testosterone suppression for trans women athletes is compelling, the injury risk at the elite level is real, and should be tackled.

While welcoming all contributions, it is simply false to state that the research is not peer-reviewed and insufficient to warrant the approach as evidenced by the numerous published studies, which consider biological advantages of males over females and the slight reduction of advantages when testosterone is suppressed.

World Rugby has operated a fully inclusive and extensive transgender guideline consultation process with relevant bodies as evidenced by the ground-breaking workshop in London. Every element was considered and input from trans advocacy groups was sought, and valued for all the reasons raised by the academics.

When the Guardian first broke the story that World Rugby was considering implementing a ban on trans women playing womens rugby, the news was immediately welcomed by some womens groups. Since then, however, a fightback from those opposed to the changes has begun.

This week the US womens player Naima Reddick joined the fray by warning the proposed ban attempts to solve a problem that isnt there.

In the decades I have spent playing, Ive learned that what truly makes someone an elite athlete isnt size, speed or strength, but mental toughness, agility and resilience, she said. Ive taken on cisgender male athletes in training and female athletes much bigger than me without hesitation because I am confident in my skill set. - Guardian

Read the original here:
World Rugby defends proposals to ban trans women from womens rugby - The Irish Times

Kevin Cash is likely facing a suspension, and Im okay with that.

Im okay with his overt threat to the Yankees because a manager must defend his players, and Im okay if Major League Baseball says that type of threat cannot be tolerated because this situation is rapidly growing dangerous.

Aroldis Chapman will almost certainly be suspended, and Im okay with that, too.

Its one thing to pitch up-and-in for effectiveness, its another thing to throw at a hitters torso to send a message, and its an entirely different world to throw a 101-mph fastball at someones head. Chapman must sit for a minimum of a week.

But Yankees manager Aaron Boone will likely skate free, and thats regrettable.

This bad blood between Tampa Bay and New York was arguably hastened by the Rays two years ago, but the Yankees have since acted like testosterone-fueled frat boys. And thats on Boone. As well as third base coach Phil Nevin, who has a history of being less-than-level-headed.

First, lets review what happened Tuesday night. Yankees starter Masahiro Tanaka, who has impeccable control, threw a pitch near Joey Wendles legs with two outs and nobody on in the first inning. On his next pitch, he drilled Wendle in the side with a 95-mph fastball, the hardest pitch he threw all night.

Was this retaliation for the Rays throwing up-and-in on D.J. LeMahieu the night before? Probably. Was it handled the right way by Tanaka? If you believe in old-school baseball justice then, yes, that was a proper response. And Cash seemed to say as much. So did Rays pitchers who did not try to hit any Yankees.

Then in the ninth inning, Chapman threw a 95-mph pitch high-and-tight on Wendle. He followed with a 99-mph pitch up-and-in on Austin Meadows. With two outs and nobody on, he uncorked a 101-mph pitch directly at the head of Mike Brosseau. The Rays infielder barely eluded the baseball as Chapman walked off the mound toward the plate.

The umpires huddled, decided to warn both benches, then automatically ejected Cash when he came out of the dugout to protest. Chapman eventually struck out Brosseau to end the game, then posed like a playground bully on the mound.

Brousseau was heading to the dugout when he clearly heard shouting from the Yankees side centerfielder Kevin Kiermaier specifically singled out Nevin for chirping and turned to say something himself. The benches emptied, but the confrontation ended quickly.

Then Cash unloaded in his postgame news conference.

Its absolutely ridiculous, he said. It was mishandled by the Yankees. Certainly, the pitcher on the mound. It was mishandled by the umpires. They hit Joey Wendle intentionally in the first inning. It was clear as day. Chapman comes in, he throws three different balls up and in. I get it they dont like being thrown up-and-in. But enoughs enough. Were talking about a 100-mph fastball over a young mans head.

Its poor judgment. Poor coaching. Its just poor teaching, what theyre doing, and what theyre allowing to do. The chirping from the dugout.

Had he stopped there, Cash would have been on solid ground. What followed was inflammatory, but also seemed purposeful. As if Cash knew he was risking suspension by drawing a line in the sand to force MLBs hand.

And the last thing Ill say on it is Ive got a whole damn stable full of guys that throw 98 mph. Period.

You could argue Cashs intent was understandable in a mutually-assured-destruction kind of way, but its hard to imagine MLB allowing a manager to threaten a beanball war, even if it was only a preemptive strike.

The umpires, who are supposed to be notified about previous altercations between teams, should have seen the situation for what it was, and immediately ejected Chapman and Boone. Their failure to act led to Cashs comments, and now will force MLB to step in today before somebody gets seriously hurt.

So how did we get here? The story is long and somewhat silly.

In September of 2018, the Rays hit Yankees with pitches in the first, second and third games of a series. The Yankees hit Rays in the second, third and fourth games of the series. After C.C. Sabathia hit Jake Bauers in that fourth game the third of four Rays he hit with a pitch that season Tampa Bays Andrew Kittredge threw near the head of Austin Romine.

It was a dangerous pitch and never should have been thrown. Kittredge was justifiably fined and suspended three games by the league. Sabathia, however, did not wait for official justice, and hit Jesus Sucre in the thigh later in the game. He was ejected, then pointed at the Rays dugout and shouted Thats for you, b---h, as he was leaving the field.

It could have ended there. It should have ended there.

Except the Yankees have continued to complain. And they seem to think every inside pitch is an affront to their glory.

The teams also exchanged taunts at Tropicana Field last month that stemmed from Nevins constant chirping. Every time a Rays pitcher got in trouble and was visited on the mound, Nevin could be heard shouting something to the effect of, Get him out of there.

When Yankees pitcher James Paxton gave up back-to-back home runs to tie the score in the seventh, it appeared Mike Zunino offered his own version of Get him out of there from the Rays dugout. The Yankees were not pleased.

Yet, from the time Sabathia walked off the mound in 2018, this has had the appearance of a one-sided feud.

Once again, there is a huge difference between pitching inside and headhunting. And there has been no indication that the Rays have tried to hit or hurt anyone in two years.

In fact, the Yankees have hit Rays batters 19 times since 2018. The Rays have hit 14 Yankees.

At this point, MLB needs to be involved. Someones career, even their life, could be jeopardized if this is allowed to escalate. And, frankly, Id be surprised if there was any intentional hit-by-pitches in Wednesdays game, considering the heightened attention.

And, just to be clear, the Rays are no choirboys in this episode, beginning with Kittredges pitch two years ago. But Tampa Bay took its punishment from Sabathia and MLB and seemed to move on.

As evidenced by Chapman last night, the Yankees have not.

John Romano can be reached at jromano@tampabay.com. Follow @romano_tbtimes.

See the article here:
This nonsense between the Yankees and Rays must stop. Immediately. - Tampa Bay Times

Page 45«..1020..44454647..5060..»

Home » Testosterone » Page 45